Literature DB >> 2657576

Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.

S R Bauer1, M Piechaczyk, R P Nordan, J D Owens, A Nepveu, K B Marcu, J F Mushinski.   

Abstract

Accumulation of unusually high amounts of larger-than-normal c-myc mRNAs occurs in two mouse plasmacytomas, TEPC 1165 and TEPC 2027. Southern blot and DNA sequence analyses showed that both tumors have undergone translocations of immunoglobulin heavy chain loci to positions 5' of the c-myc gene promotors resulting in removal of DNA sequences encoding a negative transcriptional regulatory element. In contrast to other mouse plasmacytomas, TEPC 1165 and TEPC 2027 rearranged myc genes show increased transcription, partially explaining their abundance of myc RNA. Similar to other mouse plasmacytomas, the abundance of myc RNA in TEPC 1165 and TEPC 2027 is also influenced by increased stability of structurally atypical myc RNAs. Two myc mRNAs are found in TEPC 2027, a 2.4 kb species including all 3 myc exons and a 4.0 kb species with the 3 exons plus the first intron. The two major myc mRNAs in TEPC 1165, 3.0 and 3.9 kb species, also include all three myc exons plus portions of the first intron. S1 nuclease protection analyses show that the 5' initiation and 3' untranslated (UT) regions of the unusual TEPC 1165 RNAs are normal showing that the size differences arise solely from inclusion of first intron sequences in the large myc RNAs. DNA sequence analysis showed that the presence of first intron sequences in the large myc RNAs is due to mutations affecting the splice donor region at the 3' end of exon 1 in both tumors. SDS-PAGE analysis of immunoprecipitated TEPC 1165 and TEPC 2027 myc proteins showed them to be of normal electrophoretic mobility but no more abundant than in a pre-B cell line 18-81 that contains at least 10 fold less myc RNA. The 4.0 kb myc mRNA of TEPC 2027 is atypically stable while the 2.4 kb myc mRNA undergoes normal rapid turnover within the same cell, demonstrating that the presence of first intron sequences in the large myc RNA stabilizes it despite the presence of 3' UT and putative exon 1 destabilizing sequences. These results show that myc intron 1 sequences can counteract the effect of 3' UT region destabilizing sequences in myc RNA and suggest that the increased myc RNA stability noted in TEPC 1165 and TEPC 2027 is largely due to the presence of the intron 1 sequences.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657576

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  DNA repair in the c-myc proto-oncogene locus: possible involvement in susceptibility or resistance to plasmacytoma induction in BALB/c mice.

Authors:  E J Beecham; J F Mushinski; E Shacter; M Potter; V A Bohr
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

2.  Rapid c-myc mRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA.

Authors:  I A Laird-Offringa; P Elfferich; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation.

Authors:  Alexander L Kovalchuk; Camilo Ansarah-Sobrinho; Ofir Hakim; Wolfgang Resch; Helena Tolarová; Wendy Dubois; Arito Yamane; Makiko Takizawa; Isaac Klein; Gordon L Hager; Herbert C Morse; Michael Potter; Michel C Nussenzweig; Rafael Casellas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

4.  Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction.

Authors:  S Janz; J Müller; J Shaughnessy; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Both coding exons of the c-myc gene contribute to its posttranscriptional regulation in the quiescent liver and regenerating liver and after protein synthesis inhibition.

Authors:  A Lavenu; S Pistoi; S Pournin; C Babinet; D Morello
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.